ANKRD22 and nasopharyngeal carcinoma: Flow cytometry and IF assays revealed that overexpression of ANKRD22 increased the lipid content in cells (Figure 6B and Figure S8B,C) and counteracted the effect of METTL14 knockdown on lipid content in NPC cells (Figure 6C and Figure S8D).